CARL · Carlsmed, Inc. · Executive Compensation
Market Cap
$420.46M
Shares
27.30M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Mike Cordonnier | Chief Executive Officer, President and Co-Founder Leo Greenstein | $2,789,967 |
| Scott Durall | — | $1,516,272 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Mike Cordonnier | Chief Executive Officer, President and Co-Founder Leo Greenstein | $520,693 |
| Chief Commercial | Officer | $417,087 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jeffrey Bertolini | Chief Operating Officer | Appointed | 2026-09-08 |